SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-24-194962
Filing Date
2024-08-06
Accepted
2024-08-06 17:23:04
Documents
20
Effectiveness Date
2024-08-06

Document Format Files

Seq Description Document Type Size
1 S-3ASR d840075ds3asr.htm S-3ASR 411559
2 EX-1.2 d840075dex12.htm EX-1.2 185657
3 EX-5.1 d840075dex51.htm EX-5.1 13327
4 EX-5.2 d840075dex52.htm EX-5.2 6597
5 EX-23.1 d840075dex231.htm EX-23.1 1815
6 EX-FILING FEES d840075dexfilingfees.htm   iXBRL EX-FILING FEES 111640
7 GRAPHIC g840075g44m01.jpg GRAPHIC 38699
8 GRAPHIC g840075g55m01.jpg GRAPHIC 44961
  Complete submission text file 0001193125-24-194962.txt   1053367

Data Files

Seq Description Document Type Size
22 EXTRACTED XBRL INSTANCE DOCUMENT d840075dexfilingfees_htm.xml XML 20966
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-281308 | Film No.: 241180584
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)